Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT04348045 |
| Title | Personalized Maintenance Therapy for m-PDAC Using Olaparib or Selumetinib + Durvalumab, Based on BRCAness and KRAS Status. (MAZEPPA) |
| Acronym | MAZEPPA |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | GERCOR - Multidisciplinary Oncology Cooperative Group |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | FRA |